Reuters/James Gathany/CDCAfrica stands to benefit the most from a malaria vaccine given the high prevalence rates.
https://qz.com/africa/2040120/biontech-to-develop-the-first-mrna-malaria-vaccine/
Reuters/James Gathany/CDCAfrica stands to benefit the most from a malaria vaccine given the high prevalence rates.
https://qz.com/africa/2040120/biontech-to-develop-the-first-mrna-malaria-vaccine/